Preclinical Contract Research

Pain Research

CNS Neurodegenerative Pain Studies

Preclinical Pain Research

We've helped many biopharmaceutical companies advance their innovations through preclinical efficacy phases. 

Whether the objective be to bring a compound to outlicensing stages, expand the therapeutic potential of already approved therapies or progress a compound to clinical trial phases, MD Biosciences can help. We are more than just a CRO, we are a research partner that can help design the studies based on the goals at hand. We understand the time and budget contraints that every research group is working under, whether you are a large pharma company or a small start-up. All studies are designed to maximize the amount of data that can be obtained from a single animal or cell. Additionally, we understand the link that resides between pain & inflammation and the targets that fall within the gap.

What will we bring to your project?

  • Flexibility to accomodate last minute study changes
  • Open communication so you know the status during your study
  • Scientific contribution to the study design
  • Innovative approaches to tackling problems
  • Wide range of ex vivo analysis including multiplex, PCR, histology, IHC
  • Wide range of behavior, cognitive and motor function tests
  • Willingness to validate new methods
  • IACUC and AAALAC oversight
  • GLP-like processes to bring quality and consistency to methods
How can you be sure? We'd be happy to share experiences from our sponsors. Just ask. 

 

Request Study Proposal

 

clinically relevant model of neuropathic pain

 


CONTACT US:

1-888-USMDBIO
+41-44 986 2628
email us